Phages from Ganges River curtail in vitro biofilms and planktonic growth of drug resistant Klebsiella pneumoniae in a zebrafish infection model
Open Access
- 15 February 2021
- journal article
- research article
- Published by Springer Nature in AMB Express
- Vol. 11 (1) , 1-11
Abstract
Bacteriophages are a promising alternative for curtailing infections caused by multi drug resistant (MDR) bacteria. The objective of the present study is to evaluate phage populations from water bodies to inhibit planktonic and biofilm mode of growth of drug resistant Klebsiella pneumoniae in vitro and curtail planktonic growth in vivo in a zebrafish model. Phage specific to K. pneumoniae (MTCC 432) was isolated from Ganges River (designated as KpG). One-step growth curve, in vitro time kill curve study and in vivo infection model were performed to evaluate the ability of phage to curtail planktonic growth. Crystal violet assay and colony biofilm assay were performed to determine the action of phages on biofilms. KpG phages had a greater burst size, better bactericidal potential and enhanced inhibitory effect against biofilms formed at liquid air and solid air interfaces. In vitro time kill assay showed a 3 log decline and a 6 log decline in K. pneumoniae colony counts, when phages were administered individually and in combination with streptomycin, respectively. In vivo injection of KpG phages revealed that it did not pose any toxicity to zebrafish as evidenced by liver/brain enzyme profiles and by histopathological analysis. The muscle tissue of zebrafish, infected with K. pneumoniae and treated with KpG phages alone and in combination with streptomycin showed a significant 77.7% and 97.2% decline in CFU/ml, respectively, relative to untreated control. Our study reveals that KpG phages has the potential to curtail plantonic and biofilm mode of growth in higher animal models.Keywords
All Related Versions
Funding Information
- SASTRA University ((R&M/0039/SCBT-011 /2017-2018))
This publication has 51 references indexed in Scilit:
- Characterising the biology of novel lytic bacteriophages infecting multidrug resistant Klebsiella pneumoniaeVirology Journal, 2013
- Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination TherapyClinical Infectious Diseases, 2012
- The strange history of phage therapyBacteriophage, 2012
- PhiSiGns: an online tool to identify signature genes in phages and design PCR primers for examining phage diversityBMC Bioinformatics, 2012
- Phase Variable Expression of Capsular Polysaccharide Modifications Allows Campylobacter jejuni to Avoid Bacteriophage Infection in ChickensFrontiers in Cellular and Infection Microbiology, 2012
- Phage treatment of human infectionsBacteriophage, 2011
- Characterization of a T7-Like Lytic Bacteriophage of Klebsiella pneumoniae B5055: A Potential Therapeutic AgentCurrent Microbiology, 2009
- Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in miceJournal of Medical Microbiology, 2008
- Experimental Phage Therapy against Staphylococcus aureus in MiceAntimicrobial Agents and Chemotherapy, 2007
- The TolC protein of Escherichia coli serves as a cell-surface receptor for the newly characterized TLS bacteriophage 1 1Edited by B. HollandJournal of Molecular Biology, 2001